Clinical ai leader navina secures $55m series c funding led by growth equity at goldman sachs alternatives

Investment will fuel the advancement of its ai-powered clinical intelligence platform, transforming patient care and value-based care outcomes new york , march 25, 2025 /prnewswire/ -- navina, a market leader in ai-powered clinical intelligence, today announced the successful completion of a $55 million series c funding round, bringing the total funding to $100 million. the round is led by growth equity at goldman sachs alternatives, with participation from existing investors, including vertex ventures israel, grove ventures and alive.
GS Ratings Summary
GS Quant Ranking